Novartis Pharmaceuticals Corporation v. Actavis Inc.

Application Number	Patent Number	External Links
-	US6316023	Espacenet Google Patents
-	US6335031	Espacenet Google Patents

COMPLAINT FOR PATENT INFRINGEMENT - filed against Actavis Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1244323.) - filed by Novartis Pharmaceuticals Corporation, Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., LTS Lohmann Therapie-Systeme AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(mdb) (Entered: 03/08/2013)

2013-03-07

1

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (mdb) (Entered: 03/08/2013)

2013-03-07

1

View

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/23/13. Date of Expiration of Patents: 1/8/19.Thirty Month Stay Deadline: 7/23/2015. (mdb) (Entered: 03/08/2013)

2013-03-07

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,316,023; 6,335,031;. (mdb) (Entered: 03/08/2013)

2013-03-07

1

View

Disclosure Statement pursuant to Rule 7.1 filed by LTS Lohmann Therapie-Systeme AG. (mdb) (Entered: 03/08/2013)

2013-03-07

1

View

Disclosure Statement pursuant to Rule 7.1 filed by Novartis AG. (mdb) (Entered: 03/08/2013)

2013-03-07

1

View

Disclosure Statement pursuant to Rule 7.1 filed by Novartis International Pharmaceutical Ltd. identifying Corporate Parent Novartis AG for Novartis International Pharmaceutical Ltd.. (mdb) (Entered: 03/08/2013)

2013-03-07

1

View

Disclosure Statement pursuant to Rule 7.1 filed by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation. (mdb) (Entered: 03/08/2013)

2013-03-07

1

View

Disclosure Statement pursuant to Rule 7.1 filed by Novartis Pharma AG identifying Corporate Parent Novartis AG for Novartis Pharma AG. (mdb) (Entered: 03/08/2013)

2013-03-07

1

View

No Summons Issued (mdb)

2013-03-08

1

No Actions

Summons Issued with Magistrate Consent Notice attached as to Actavis Inc. on 3/8/2013; Watson Laboratories Inc. on 3/8/2013; Watson Pharma Inc. on 3/8/2013; Watson Pharmaceuticals Inc. on 3/8/2013. (mdb)

2013-03-08

1

No Actions

AFFIDAVIT of Service for Summons served on Actavis Inc., Watson Pharmaceuticals, Inc., and Watson Laboratories, Inc. on March 11, 2013, filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit A - C)(Silver, Daniel) Modified on 3/12/2013 per filer's request(bkb). (Entered: 03/12/2013)

2013-03-12

1

View

SUMMONS Returned Executed by Novartis Pharmaceuticals Corporation, Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., LTS Lohmann Therapie-Systeme AG. Watson Pharma Inc. served on 3/11/2013, answer due 4/1/2013. (Silver, Daniel) (Entered: 03/12/2013)

2013-03-12

1

View

CORRECTING ENTRY: Service date in DI 10 changed from 3/12/13 to 3/11/13 per request of filer. (bkb)

2013-03-12

1

No Actions

Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:13-cv-00370-RGA, 1:13-cv-00371-RGA (rjb)

2013-03-13

1

No Actions

MOTION for Pro Hac Vice Appearance of Attorney Christopher Loh, Attorney Nicholas Kallas and Attorney Filko Prugo - filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Pro Hac Vice Certification of Christoher Loh, # 2 Pro Hac Vice Certification of Nicholas Kallas, # 3 Pro Hac Vice Certification of Filko Prugo)(Silver, Daniel) (Entered: 03/14/2013)

2013-03-14

1

View

SO ORDERED, re 12 MOTION for Pro Hac Vice Appearance of Attorney Christopher Loh, Attorney Nicholas Kallas and Attorney Filko Prugo filed by Novartis International Pharmaceutical Ltd., LTS Lohmann Therapie-Systeme AG, Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation. Signed by Judge Richard G. Andrews on 3/14/2013. (nms)

2013-03-14

1

No Actions

Disclosure Statement pursuant to Rule 7.1 filed by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc. identifying Corporate Parent Actavis, Inc. for Watson Laboratories Inc., Watson Pharma Inc... (Vrana, Robert) (Entered: 04/01/2013)

2013-04-01

1

View

ANSWER to 1 Complaint, Afirmative Defenses and, COUNTERCLAIM against LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation by Watson Pharma Inc., Watson Pharmaceuticals Inc., Watson Laboratories Inc..(Sharp, Melanie) (Entered: 04/01/2013)

2013-04-01

1

View

Pro Hac Vice Attorney Nicholas Kallas,Christopher E. Loh,Filko Prugo for Novartis International Pharmaceutical Ltd. added for electronic noticing. (dmp, )

2013-04-04

1

No Actions

Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 5/14/2013, at 1:30 PM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 4/16/2013. (nms) (Entered: 04/16/2013)

2013-04-16

1

View

REPLY to 14 Answer to Complaint, Counterclaim, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) Modified on 4/29/2013 (nms). (Entered: 04/25/2013)

2013-04-25

1

View

STIPULATION and [Proposed] Order Staying Litigation by Actavis Inc., LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Silver, Daniel) (Entered: 05/10/2013)

2013-05-10

1

View

SO ORDERED Granting 17 Stipulation and Proposed Order Staying Litigation, filed by Watson Pharma Inc., Actavis Inc., LTS Lohmann Therapie-Systeme AG, Novartis International Pharmaceutical Ltd., Novartis AG, Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Watson Laboratories Inc., Watson Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 5/13/2013. (nms) (Entered: 05/13/2013)

2013-05-13

1

View

ORAL ORDER: The Rule 16(b) Conference scheduled for 5/14/2013, is CANCELED pursuant to the matter being stayed by D.I. 18 . Ordered by Judge Richard G. Andrews on 5/13/2013. (nms)

2013-05-13

1

No Actions

ORDER Administratively Closing Case. Signed by Judge Richard G. Andrews on 5/15/2013. (nms) (Entered: 05/15/2013)

2013-05-15

1

View

NOTICE of Withdrawal of Certain Counsel Admitted Pro Hac Vice by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation (Silver, Daniel) (Entered: 04/09/2014)

2014-04-09

1

View

MOTION for Pro Hac Vice Appearance of Attorney Dominick A. Conde - filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Certification by Counsel for Dominick A. Conde)(Silver, Daniel) (Entered: 04/10/2014)

2014-04-10

1

View

SO ORDERED, re (111 in 1:13-cv-00527-RGA, 150 in 1:13-cv-00052-RGA, 38 in 1:13-cv-01467-RGA, 21 in 1:13-cv-00371-RGA, 373 in 1:11-cv-01077-RGA) MOTION for Pro Hac Vice Appearance of Attorney Dominick A. Conde, filed by Novartis International Pharmaceutical Ltd., LTS Lohmann Therapie-Systeme AG, Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation. Signed by Judge Richard G. Andrews on 4/10/2014. Associated Cases: 1:11-cv-01077-RGA, 1:13-cv-00052-RGA, 1:13-cv-00371-RGA, 1:13-cv-00527-RGA, 1:13-cv-01467-RGA(nms)

2014-04-10

1

No Actions

Pro Hac Vice Attorney Dominick A. Conde for Novartis Pharmaceuticals Corporation added for electronic noticing. Associated Cases: 1:11-cv-01077-RGA, 1:13-cv-00052-RGA, 1:13-cv-00371-RGA, 1:13-cv-00527-RGA, 1:13-cv-01467-RGA(dmp, )

2014-04-11

1

No Actions

NOTICE of Petition for Inter Partes Review of the Patents-In-Suit Before the Patent Trial and Appeal Board by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Silver, Daniel) (Entered: 05/08/2014)

2014-05-08

1

View

PROPOSED Final Judgment, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 7/18/2014 (nms). (Entered: 07/17/2014)

2014-07-17

1

View

FINAL JUDGMENT (see Judgment for further details) (CASE CLOSED). Signed by Judge Richard G. Andrews on 8/4/2014. (nms) (Entered: 08/04/2014)

2014-08-04

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,316,023; 6,335,031. (Attachments: # 1 Judgment)(nms) (Entered: 08/05/2014)

2014-08-05

1

View

NOTICE of Appearance by John C. Phillips, Jr on behalf of Actavis Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc. (Phillips, John) (Entered: 09/03/2014)

2014-09-03

1

View

NOTICE of Appearance by Megan C. Haney on behalf of Actavis Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc. (Haney, Megan) (Entered: 09/03/2014)

2014-09-03

1

View

NOTICE OF APPEAL to the Federal Circuit of 24 Judgment . Appeal filed by Actavis Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Phillips, John) (Entered: 09/03/2014)

2014-09-03

1

View

NOTICE of Withdrawal of Counsel by Actavis Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc. (Vrana, Robert) (Entered: 09/03/2014)

2014-09-03

1

View

APPEAL - Credit Card Payment of $505.00 received re 28 Notice of Appeal (Federal Circuit) filed by Watson Pharma Inc., Actavis Inc., Watson Laboratories Inc., Watson Pharmaceuticals Inc.. ( Filing fee $505, receipt number 0311-1581092.) (Phillips, John)

2014-09-03

1

No Actions

Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re 28 Notice of Appeal (Federal Circuit). (dmp, )

2014-09-04

1

No Actions

NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 28 Notice of Appeal (Federal Circuit), filed by Watson Pharma Inc., Actavis Inc., Watson Laboratories Inc., Watson Pharmaceuticals Inc.. USCA Case Number 14-1800. (nms) (Entered: 09/08/2014)

2014-09-08

1

View

TRANSCRIPT REQUEST by Actavis Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc. Transcript Not Needed (Haney, Megan) (Entered: 09/17/2014)

2014-09-17

1

View

MANDATE of USCA as to 28 Notice of Appeal (Federal Circuit), filed by Watson Pharma Inc., Actavis Inc., Watson Laboratories Inc., Watson Pharmaceuticals Inc.. USCA Decision: affirmed. (Attachments: # 1 Opinion)(nms) (Entered: 06/30/2015)

2015-06-30

1

View

Overview

Parties

Defendant

Watson Pharma Inc. Follow

Represented By

Watson Laboratories Inc. Follow

Represented By

Watson Pharmaceuticals Inc. Follow

Represented By

Actavis Inc. Follow

Represented By

Plaintiff

LTS Lohmann Therapie-Systeme AG Follow

Represented By

Novartis International Pharmaceutical Ltd. Follow

Represented By

Novartis Pharma AG Follow

Represented By

Novartis AG Follow

Represented By

Novartis Pharmaceuticals Corporation Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (mdb) (Entered: 03/08/2013)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/23/13. Date of Expiration of Patents: 1/8/19.Thirty Month Stay Deadline: 7/23/2015. (mdb) (Entered: 03/08/2013)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,316,023; 6,335,031;. (mdb) (Entered: 03/08/2013)

Disclosure Statement pursuant to Rule 7.1 filed by LTS Lohmann Therapie-Systeme AG. (mdb) (Entered: 03/08/2013)

Disclosure Statement pursuant to Rule 7.1 filed by Novartis AG. (mdb) (Entered: 03/08/2013)

Disclosure Statement pursuant to Rule 7.1 filed by Novartis International Pharmaceutical Ltd. identifying Corporate Parent Novartis AG for Novartis International Pharmaceutical Ltd.. (mdb) (Entered: 03/08/2013)

Disclosure Statement pursuant to Rule 7.1 filed by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation. (mdb) (Entered: 03/08/2013)

Disclosure Statement pursuant to Rule 7.1 filed by Novartis Pharma AG identifying Corporate Parent Novartis AG for Novartis Pharma AG. (mdb) (Entered: 03/08/2013)

No Summons Issued (mdb)

Summons Issued with Magistrate Consent Notice attached as to Actavis Inc. on 3/8/2013; Watson Laboratories Inc. on 3/8/2013; Watson Pharma Inc. on 3/8/2013; Watson Pharmaceuticals Inc. on 3/8/2013. (mdb)

SUMMONS Returned Executed by Novartis Pharmaceuticals Corporation, Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., LTS Lohmann Therapie-Systeme AG. Watson Pharma Inc. served on 3/11/2013, answer due 4/1/2013. (Silver, Daniel) (Entered: 03/12/2013)

CORRECTING ENTRY: Service date in DI 10 changed from 3/12/13 to 3/11/13 per request of filer. (bkb)

Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:13-cv-00370-RGA, 1:13-cv-00371-RGA (rjb)

Disclosure Statement pursuant to Rule 7.1 filed by Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc. identifying Corporate Parent Actavis, Inc. for Watson Laboratories Inc., Watson Pharma Inc... (Vrana, Robert) (Entered: 04/01/2013)

Pro Hac Vice Attorney Nicholas Kallas,Christopher E. Loh,Filko Prugo for Novartis International Pharmaceutical Ltd. added for electronic noticing. (dmp, )

Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 5/14/2013, at 1:30 PM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 4/16/2013. (nms) (Entered: 04/16/2013)

REPLY to 14 Answer to Complaint, Counterclaim, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) Modified on 4/29/2013 (nms). (Entered: 04/25/2013)

ORAL ORDER: The Rule 16(b) Conference scheduled for 5/14/2013, is CANCELED pursuant to the matter being stayed by D.I. 18 . Ordered by Judge Richard G. Andrews on 5/13/2013. (nms)

ORDER Administratively Closing Case. Signed by Judge Richard G. Andrews on 5/15/2013. (nms) (Entered: 05/15/2013)

NOTICE of Withdrawal of Certain Counsel Admitted Pro Hac Vice by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation (Silver, Daniel) (Entered: 04/09/2014)

Pro Hac Vice Attorney Dominick A. Conde for Novartis Pharmaceuticals Corporation added for electronic noticing. Associated Cases: 1:11-cv-01077-RGA, 1:13-cv-00052-RGA, 1:13-cv-00371-RGA, 1:13-cv-00527-RGA, 1:13-cv-01467-RGA(dmp, )

PROPOSED Final Judgment, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 7/18/2014 (nms). (Entered: 07/17/2014)

FINAL JUDGMENT (see Judgment for further details) (CASE CLOSED). Signed by Judge Richard G. Andrews on 8/4/2014. (nms) (Entered: 08/04/2014)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,316,023; 6,335,031. (Attachments: # 1 Judgment)(nms) (Entered: 08/05/2014)

NOTICE of Appearance by John C. Phillips, Jr on behalf of Actavis Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc. (Phillips, John) (Entered: 09/03/2014)

NOTICE of Appearance by Megan C. Haney on behalf of Actavis Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc. (Haney, Megan) (Entered: 09/03/2014)

NOTICE OF APPEAL to the Federal Circuit of 24 Judgment . Appeal filed by Actavis Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc.. (Phillips, John) (Entered: 09/03/2014)

NOTICE of Withdrawal of Counsel by Actavis Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc. (Vrana, Robert) (Entered: 09/03/2014)

APPEAL - Credit Card Payment of $505.00 received re 28 Notice of Appeal (Federal Circuit) filed by Watson Pharma Inc., Actavis Inc., Watson Laboratories Inc., Watson Pharmaceuticals Inc.. ( Filing fee $505, receipt number 0311-1581092.) (Phillips, John)

Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re 28 Notice of Appeal (Federal Circuit). (dmp, )

NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 28 Notice of Appeal (Federal Circuit), filed by Watson Pharma Inc., Actavis Inc., Watson Laboratories Inc., Watson Pharmaceuticals Inc.. USCA Case Number 14-1800. (nms) (Entered: 09/08/2014)

TRANSCRIPT REQUEST by Actavis Inc., Watson Laboratories Inc., Watson Pharma Inc., Watson Pharmaceuticals Inc. Transcript Not Needed (Haney, Megan) (Entered: 09/17/2014)

MANDATE of USCA as to 28 Notice of Appeal (Federal Circuit), filed by Watson Pharma Inc., Actavis Inc., Watson Laboratories Inc., Watson Pharmaceuticals Inc.. USCA Decision: affirmed. (Attachments: # 1 Opinion)(nms) (Entered: 06/30/2015)

Track Case Updates

Watson Pharma Inc.

Watson Laboratories Inc.

Watson Pharmaceuticals Inc.

Actavis Inc.

LTS Lohmann Therapie-Systeme AG

Novartis International Pharmaceutical Ltd.

Novartis Pharma AG

Novartis AG

Novartis Pharmaceuticals Corporation